{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Centipeda minima", "brevilin A", "caspase-8", "extrinsic apoptosis", "network pharmacology"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35807611", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "23"}], "Language": ["eng"], "ELocationID": ["1658", "10.3390/plants11131658"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "11", "Issue": "13", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "23"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "Brevilin A Isolated from <i>Centipeda minima</i> Induces Apoptosis in Human Gastric Cancer Cells via an Extrinsic Apoptotic Signaling Pathway.", "Abstract": {"AbstractText": ["Brevilin A, which has anticancer activities against a range of cancers, is an abundant constituent of the medicinal herb <i>Centipeda minima</i> (L.) A. Braun & Asch, which has also been reported to have anticancer activity against breast cancer cells. However, the anticancer activities of <i>C. minima</i> and brevilin A against human gastric cancer have yet to be reported. In this study, we aimed to evaluate the cytotoxicity and molecular basis underlying the anticancer activities of extracts of <i>C. minima</i> (CMX) and brevilin A against human gastric cancer (AGS) cells. We deduced the potential targets and mechanisms underlying the anticancer activity of brevilin A based on a network pharmacology approach. CCND1, CDK4, and BCL2L1 were identified as the key anticancer genes targeted by brevilin A. Cytotoxicity analyses revealed that CMX and brevilin A reduced the viability of AGS cells to levels below 50% (9.73 \u00b1 1.29 \u00b5g/mL and 54.69 \u00b1 1.38 \u03bcM, respectively). Furthermore, Hoechst 33342, annexin V, and propidium iodide staining and western blot analyses revealed that CMX and brevilin A promoted a significant induction of apoptotic cell death by upregulating the expression of cleaved caspase-8 and cleaved caspase-3 and reducing the ratio of Bax to Bcl-2, which is partially consistent with the findings of our network pharmacology analysis. Collectively, our observations indicate that CMX and brevilin A are novel sources of herbal medicine with potential utility as effective agents for the treatment of gastric cancer."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Gachon University, Seongnam 13120, Korea."}], "LastName": "Lee", "ForeName": "Dahae", "Initials": "D"}, {"Identifier": ["0000-0001-6171-2552"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, Korea."}], "LastName": "Kwak", "ForeName": "Hee Jae", "Initials": "HJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "D. Nature Co., Ltd., Seongnam 13174, Korea."}], "LastName": "Kim", "ForeName": "Byoung Ha", "Initials": "BH"}, {"Identifier": ["0000-0002-9756-785X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Wonkwang University, Iksan 54538, Korea."}], "LastName": "Kim", "ForeName": "Dong-Wook", "Initials": "DW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science and Nutrition, Gyeongsang National University, Jinju 52725, Korea."}], "LastName": "Kim", "ForeName": "Hyun Young", "Initials": "HY"}, {"Identifier": ["0000-0003-2613-0674"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, Korea."}], "LastName": "Kim", "ForeName": "Seung Hyun", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Korean Medicine, Gachon University, Seongnam 13120, Korea."}], "LastName": "Kang", "ForeName": "Ki Sung", "Initials": "KS"}], "GrantList": [{"GrantID": "2020M3A9E4104380", "Agency": "National Research Foundation", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Lee M.M.-L., Chan B.D., Wong W.-Y., Qu Z., Chan M.-S., Leung T.-W., Lin Y., Mok D.K.-W., Chen S., Tai W.C.-S. Anti-cancer activity of Centipeda minima extract in triple negative breast cancer via inhibition of AKT, NF-\u03baB, and STAT3 signaling pathways. Front. Oncol. 2020;10:491. doi: 10.3389/fonc.2020.00491.", "ArticleIdList": ["10.3389/fonc.2020.00491", "PMC7160338", "32328465"]}, {"Citation": "Guo Y.-Q., Sun H.-Y., Chan C.-O., Liu B.-B., Wu J.-H., Chan S.-W., Mok D.K.-W., Tse A.K.-W., Yu Z.-L., Chen S.-B. Centipeda minima (Ebushicao) extract inhibits PI3K-Akt-mTOR signaling in nasopharyngeal carcinoma CNE-1 cells. Chin. Med. 2015;10:26. doi: 10.1186/s13020-015-0058-5.", "ArticleIdList": ["10.1186/s13020-015-0058-5", "PMC4575463", "26388933"]}, {"Citation": "Maqbool M.F., Ashaq A., Maryam A., Khan M., Ali M.A., Shakir H.A., Gul S., Shakoori F.R., Irfan M., Ara C. Unraveling the Anticancer Components of Centipeda minima and their Cellular Targets in Human Cancers. J. Biol. Act. Prod. Nat. 2022;12:42\u201364. doi: 10.1080/22311866.2021.2016485.", "ArticleIdList": ["10.1080/22311866.2021.2016485"]}, {"Citation": "Liu R., Dow Chan B., Mok D.K.-W., Lee C.-S., Tai W.C.-S., Chen S. Arnicolide D, from the herb Centipeda minima, is a therapeutic candidate against nasopharyngeal carcinoma. Molecules. 2019;24:1908. doi: 10.3390/molecules24101908.", "ArticleIdList": ["10.3390/molecules24101908", "PMC6571971", "31108969"]}, {"Citation": "Lee M.M.-L., Chan B.D., Wong W.-Y., Leung T.-W., Qu Z., Huang J., Zhu L., Lee C.-S., Chen S., Tai W.C.-S. Synthesis and evaluation of novel anticancer compounds derived from the natural product Brevilin A. ACS Omega. 2020;5:14586\u201314596. doi: 10.1021/acsomega.0c01276.", "ArticleIdList": ["10.1021/acsomega.0c01276", "PMC7315608", "32596596"]}, {"Citation": "Qin Y., Lu H. In vitro evaluation of anti-hepatoma activity of brevilin A: Involvement of Stat3/Snail and Wnt/\u03b2-catenin pathways. RSC Adv. 2019;9:4390\u20134396. doi: 10.1039/C8RA08574A.", "ArticleIdList": ["10.1039/C8RA08574A", "PMC9088035", "35547606"]}, {"Citation": "Su T., Wang Y.-P., Wang X.-N., Li C.-Y., Zhu P.-L., Huang Y.-M., Yang Z.-Y., Chen S.-B., Yu Z.-L. The JAK2/STAT3 pathway is involved in the anti-melanoma effects of brevilin A. Life Sci. 2020;241:117169. doi: 10.1016/j.lfs.2019.117169.", "ArticleIdList": ["10.1016/j.lfs.2019.117169", "31843524"]}, {"Citation": "Zhang X., Xia Y., Yang L., He J., Li Y., Xia C. Brevilin a, a sesquiterpene lactone, inhibits the replication of influenza a virus in vitro and in vivo. Viruses. 2019;11:835. doi: 10.3390/v11090835.", "ArticleIdList": ["10.3390/v11090835", "PMC6783993", "31500389"]}, {"Citation": "Yu H., Wright C., Cai Y., Yang S., Phillipson J., Kirby G., Warhurst D. Antiprotozoal activities of Centipeda minima. Phytother. Res. 1994;8:436\u2013438. doi: 10.1002/ptr.2650080713.", "ArticleIdList": ["10.1002/ptr.2650080713"]}, {"Citation": "Qin Q., Xu G., Zhan X., Wang Z., Wang Y., Liu H., Hou X., Shi W., Ma J., Bai Z. Brevilin A inhibits NLRP3 inflammasome activation in vivo and in vitro by acting on the upstream of NLRP3-induced ASC oligomerization. Mol. Immunol. 2021;135:116\u2013126. doi: 10.1016/j.molimm.2021.03.025.", "ArticleIdList": ["10.1016/j.molimm.2021.03.025", "33892379"]}, {"Citation": "Kim B.H., Lee M.J., Lee W.Y., Pyo J., Shin M.S., Hwang G.S., Shin D., Kim C.E., Park E.S., Kang K.S. Hair Growth Stimulation Effect of Centipeda minima Extract: Identification of Active Compounds and Anagen-Activating Signaling Pathways. Biomolecules. 2021;11:976. doi: 10.3390/biom11070976.", "ArticleIdList": ["10.3390/biom11070976", "PMC8301965", "34356600"]}, {"Citation": "Hopkins A.L. Network pharmacology: The next paradigm in drug discovery. Nat. Chem. Biol. 2008;4:682\u2013690. doi: 10.1038/nchembio.118.", "ArticleIdList": ["10.1038/nchembio.118", "18936753"]}, {"Citation": "Lee D., Kwak H.J., Kim B.H., Kim S.H., Kim D.-W., Kang K.S. Combined Anti-Adipogenic Effects of Hispidulin and p-Synephrine on 3T3-L1 Adipocytes. Biomolecules. 2021;11:1764. doi: 10.3390/biom11121764.", "ArticleIdList": ["10.3390/biom11121764", "PMC8698582", "34944408"]}, {"Citation": "He S., Wang T., Shi C., Wang Z., Fu X. Network pharmacology-based approach to understand the effect and mechanism of Danshen against anemia. J. Ethnopharmacol. 2022;282:114615. doi: 10.1016/j.jep.2021.114615.", "ArticleIdList": ["10.1016/j.jep.2021.114615", "34509606"]}, {"Citation": "Golbeck J. Introduction to Social Media Investigation: A Hands-On Approach. Syngress; Rockland, MA, USA: 2015."}, {"Citation": "Hansen D., Shneiderman B., Smith M.A. Analyzing Social Media Networks with NodeXL: Insights from a Connected World. Morgan Kaufmann; Los Angeles, CA, USA: 2010."}, {"Citation": "Metcalf L., Casey W. Cybersecurity and Applied Mathematics. Syngress; Rockland, MA, USA: 2016."}, {"Citation": "Zhang S., Yu D. Targeting Src family kinases in anti-cancer therapies: Turning promise into triumph. Trends Pharmacol. Sci. 2012;33:122\u2013128. doi: 10.1016/j.tips.2011.11.002.", "ArticleIdList": ["10.1016/j.tips.2011.11.002", "PMC3675659", "22153719"]}, {"Citation": "Simatou A., Simatos G., Goulielmaki M., Spandidos D.A., Baliou S., Zoumpourlis V. Historical retrospective of the SRC oncogene and new perspectives. Mol. Clin. Oncol. 2020;13:1\u201310. doi: 10.3892/mco.2020.2091.", "ArticleIdList": ["10.3892/mco.2020.2091", "PMC7403812", "32765869"]}, {"Citation": "Montalto F.I., De Amicis F. Cyclin D1 in cancer: A molecular connection for cell cycle control, adhesion and invasion in tumor and stroma. Cells. 2020;9:2648. doi: 10.3390/cells9122648.", "ArticleIdList": ["10.3390/cells9122648", "PMC7763888", "33317149"]}, {"Citation": "Chou J., Quigley D.A., Robinson T.M., Feng F.Y., Ashworth A. Transcription-associated cyclin-dependent kinases as targets and biomarkers for cancer therapy. Cancer Discov. 2020;10:351\u2013370. doi: 10.1158/2159-8290.CD-19-0528.", "ArticleIdList": ["10.1158/2159-8290.CD-19-0528", "32071145"]}, {"Citation": "He W., Zhu Y., Mu R., Xu J., Zhang X., Wang C., Li Q., Huang Z., Zhang J., Pan Y. A Jak2-selective inhibitor potently reverses the immune suppression by modulating the tumor microenvironment for cancer immunotherapy. Biochem. Pharmacol. 2017;145:132\u2013146. doi: 10.1016/j.bcp.2017.08.019.", "ArticleIdList": ["10.1016/j.bcp.2017.08.019", "28859967"]}, {"Citation": "Luttman J.H., Colemon A., Mayro B., Pendergast A.M. Role of the ABL tyrosine kinases in the epithelial\u2013mesenchymal transition and the metastatic cascade. Cell Commun. Signal. 2021;19:1\u201316. doi: 10.1186/s12964-021-00739-6.", "ArticleIdList": ["10.1186/s12964-021-00739-6", "PMC8140471", "34022881"]}, {"Citation": "Dey N., De P., Leyland-Jones B. PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials. Pharmacol. Ther. 2017;175:91\u2013106. doi: 10.1016/j.pharmthera.2017.02.037.", "ArticleIdList": ["10.1016/j.pharmthera.2017.02.037", "28216025"]}, {"Citation": "Polivka J., Jr., Janku F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol. Ther. 2014;142:164\u2013175. doi: 10.1016/j.pharmthera.2013.12.004.", "ArticleIdList": ["10.1016/j.pharmthera.2013.12.004", "24333502"]}, {"Citation": "Thomas S.J., Snowden J.A., Zeidler M.P., Danson S.J. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br. J. Cancer. 2015;113:365\u2013371. doi: 10.1038/bjc.2015.233.", "ArticleIdList": ["10.1038/bjc.2015.233", "PMC4522639", "26151455"]}, {"Citation": "Wang Q., He G., Hou M., Chen L., Chen S., Xu A., Fu Y. Cell cycle regulation by alternative polyadenylation of CCND1. Sci. Rep. 2018;8:6824. doi: 10.1038/s41598-018-25141-0.", "ArticleIdList": ["10.1038/s41598-018-25141-0", "PMC5931507", "29717174"]}, {"Citation": "Baker S.J., Reddy E.P. CDK4: A key player in the cell cycle, development, and cancer. Genes Cancer. 2012;3:658\u2013669. doi: 10.1177/1947601913478972.", "ArticleIdList": ["10.1177/1947601913478972", "PMC3636745", "23634254"]}, {"Citation": "Shan Y.S., Hsu H.P., Lai M.D., Hung Y.H., Wang C.Y., Yen M.C., Chen Y.L. Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer. Oncol. Lett. 2017;14:4517\u20134526. doi: 10.3892/ol.2017.6736.", "ArticleIdList": ["10.3892/ol.2017.6736", "PMC5594254", "28943959"]}, {"Citation": "Sillars-Hardebol A.H., Carvalho B., Beli\u00ebn J.A., de Wit M., Delis-van Diemen P.M., Tijssen M., van de Wiel M.A., Pont\u00e9n F., Fijneman R.J., Meijer G.A. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain. J. Pathol. 2012;226:442\u2013450. doi: 10.1002/path.2983.", "ArticleIdList": ["10.1002/path.2983", "22009326"]}, {"Citation": "Elbadawy M., Usui T., Yamawaki H., Sasaki K. Development of an experimental model for analyzing drug resistance in colorectal cancer. Cancers. 2018;10:164. doi: 10.3390/cancers10060164.", "ArticleIdList": ["10.3390/cancers10060164", "PMC6025190", "29843359"]}, {"Citation": "Trisciuoglio D., Tupone M.G., Desideri M., Di Martile M., Gabellini C., Buglioni S., Pallocca M., Alessandrini G., D\u2019Aguanno S., Del Bufalo D. BCL-X L overexpression promotes tumor progression-associated properties. Cell Death Dis. 2017;8:3216. doi: 10.1038/s41419-017-0055-y.", "ArticleIdList": ["10.1038/s41419-017-0055-y", "PMC5870591", "29238043"]}, {"Citation": "Ton\u00e9 S., Sugimoto K., Tanda K., Suda T., Uehira K., Kanouchi H., Samejima K., Minatogawa Y., Earnshaw W.C. Three distinct stages of apoptotic nuclear condensation revealed by time-lapse imaging, biochemical and electron microscopy analysis of cell-free apoptosis. Exp. Cell Res. 2007;313:3635\u20133644. doi: 10.1016/j.yexcr.2007.06.018.", "ArticleIdList": ["10.1016/j.yexcr.2007.06.018", "PMC2705844", "17643424"]}, {"Citation": "Elmore S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007;35:495\u2013516. doi: 10.1080/01926230701320337.", "ArticleIdList": ["10.1080/01926230701320337", "PMC2117903", "17562483"]}, {"Citation": "Huang K., Zhang J., O\u2019Neill K.L., Gurumurthy C.B., Quadros R.M., Tu Y., Luo X. Cleavage by caspase 8 and mitochondrial membrane association activate the BH3-only protein Bid during TRAIL-induced apoptosis. J. Biol. Chem. 2016;291:11843\u201311851. doi: 10.1074/jbc.M115.711051.", "ArticleIdList": ["10.1074/jbc.M115.711051", "PMC4882451", "27053107"]}, {"Citation": "Parrish A.B., Freel C.D., Kornbluth S. Cellular mechanisms controlling caspase activation and function. Cold Spring Harb. Perspect. Biol. 2013;5:a008672. doi: 10.1101/cshperspect.a008672.", "ArticleIdList": ["10.1101/cshperspect.a008672", "PMC3660825", "23732469"]}, {"Citation": "McIlwain D.R., Berger T., Mak T.W. Caspase functions in cell death and disease. Cold Spring Harb. Perspect. Biol. 2013;5:a008656. doi: 10.1101/cshperspect.a008656.", "ArticleIdList": ["10.1101/cshperspect.a008656", "PMC3683896", "23545416"]}, {"Citation": "Gfeller D., Michielin O., Zoete V. Shaping the interaction landscape of bioactive molecules. Bioinformatics. 2013;29:3073\u20133079. doi: 10.1093/bioinformatics/btt540.", "ArticleIdList": ["10.1093/bioinformatics/btt540", "24048355"]}, {"Citation": "Venny O.J.C. An Interactive Tool for Comparing Lists with Venn Diagrams. 2007.  [(accessed on 18 August 2021)].  Available online:  http://bioinfogp.cnb.csic.es/tools/venny/index.html."}, {"Citation": "Pi\u00f1ero J., Ram\u00edrez-Anguita J.M., Sa\u00fcch-Pitarch J., Ronzano F., Centeno E., Sanz F., Furlong L.I. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020;48:D845\u2013D855. doi: 10.1093/nar/gkz1021.", "ArticleIdList": ["10.1093/nar/gkz1021", "PMC7145631", "31680165"]}, {"Citation": "Szklarczyk D., Gable A.L., Nastou K.C., Lyon D., Kirsch R., Pyysalo S., Doncheva N.T., Legeay M., Fang T., Bork P. The STRING database in 2021: Customizable protein\u2013protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605\u2013D612. doi: 10.1093/nar/gkaa1074.", "ArticleIdList": ["10.1093/nar/gkaa1074", "PMC7779004", "33237311"]}, {"Citation": "Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u20132504. doi: 10.1101/gr.1239303.", "ArticleIdList": ["10.1101/gr.1239303", "PMC403769", "14597658"]}, {"Citation": "Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009;4:44\u201357. doi: 10.1038/nprot.2008.211.", "ArticleIdList": ["10.1038/nprot.2008.211", "19131956"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "24"}, {"Year": "2022", "Month": "6", "Day": "19"}, {"Year": "2022", "Month": "6", "Day": "20"}, {"Year": "2022", "Month": "7", "Day": "9", "Hour": "1", "Minute": "20"}, {"Year": "2022", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "10", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["35807611", "PMC9268799", "10.3390/plants11131658", "plants11131658"]}}], "PubmedBookArticle": []}